Germline mutations in MSH2 and MLH1 account for approximately 60% of HNPCC, while nearly one-third of HNPCC patients do not show MMR gene mutations, which may be attribute to epigenetic silencing [8–11]. The gene discussed is MSH2; the disease is hereditary nonpolyposis colon cancer.